247 related articles for article (PubMed ID: 25032849)
1. Caveolin-1 is required for TGF-β-induced transactivation of the EGF receptor pathway in hepatocytes through the activation of the metalloprotease TACE/ADAM17.
Moreno-Càceres J; Caja L; Mainez J; Mayoral R; Martín-Sanz P; Moreno-Vicente R; Del Pozo MÁ; Dooley S; Egea G; Fabregat I
Cell Death Dis; 2014 Jul; 5(7):e1326. PubMed ID: 25032849
[TBL] [Abstract][Full Text] [Related]
2. Caveolin-1-dependent activation of the metalloprotease TACE/ADAM17 by TGF-β in hepatocytes requires activation of Src and the NADPH oxidase NOX1.
Moreno-Càceres J; Mainez J; Mayoral R; Martín-Sanz P; Egea G; Fabregat I
FEBS J; 2016 Apr; 283(7):1300-10. PubMed ID: 26815118
[TBL] [Abstract][Full Text] [Related]
3. Caveolin-1 negatively regulates a metalloprotease-dependent epidermal growth factor receptor transactivation by angiotensin II.
Takaguri A; Shirai H; Kimura K; Hinoki A; Eguchi K; Carlile-Klusacek M; Yang B; Rizzo V; Eguchi S
J Mol Cell Cardiol; 2011 Mar; 50(3):545-51. PubMed ID: 21172357
[TBL] [Abstract][Full Text] [Related]
4. Differential intracellular signalling induced by TGF-beta in rat adult hepatocytes and hepatoma cells: implications in liver carcinogenesis.
Caja L; Ortiz C; Bertran E; Murillo MM; Miró-Obradors MJ; Palacios E; Fabregat I
Cell Signal; 2007 Apr; 19(4):683-94. PubMed ID: 17055226
[TBL] [Abstract][Full Text] [Related]
5. Involvement of EGF receptor and c-Src in the survival signals induced by TGF-beta1 in hepatocytes.
Murillo MM; del Castillo G; Sánchez A; Fernández M; Fabregat I
Oncogene; 2005 Jun; 24(28):4580-7. PubMed ID: 15856020
[TBL] [Abstract][Full Text] [Related]
6. The level of caveolin-1 expression determines response to TGF-β as a tumour suppressor in hepatocellular carcinoma cells.
Moreno-Càceres J; Caballero-Díaz D; Nwosu ZC; Meyer C; López-Luque J; Malfettone A; Lastra R; Serrano T; Ramos E; Dooley S; Fabregat I
Cell Death Dis; 2017 Oct; 8(10):e3098. PubMed ID: 29022911
[TBL] [Abstract][Full Text] [Related]
7. Activation of NADPH oxidase by transforming growth factor-beta in hepatocytes mediates up-regulation of epidermal growth factor receptor ligands through a nuclear factor-kappaB-dependent mechanism.
Murillo MM; Carmona-Cuenca I; Del Castillo G; Ortiz C; Roncero C; Sánchez A; Fernández M; Fabregat I
Biochem J; 2007 Jul; 405(2):251-9. PubMed ID: 17407446
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial reactive oxygen species mediate GPCR-induced TACE/ADAM17-dependent transforming growth factor-alpha shedding.
Myers TJ; Brennaman LH; Stevenson M; Higashiyama S; Russell WE; Lee DC; Sunnarborg SW
Mol Biol Cell; 2009 Dec; 20(24):5236-49. PubMed ID: 19846666
[TBL] [Abstract][Full Text] [Related]
9. HB-EGF release mediates glucose-induced activation of the epidermal growth factor receptor in mesangial cells.
Uttarwar L; Peng F; Wu D; Kumar S; Gao B; Ingram AJ; Krepinsky JC
Am J Physiol Renal Physiol; 2011 Apr; 300(4):F921-31. PubMed ID: 21289053
[TBL] [Abstract][Full Text] [Related]
10. Caveolin 1 is critical for abdominal aortic aneurysm formation induced by angiotensin II and inhibition of lysyl oxidase.
Takayanagi T; Crawford KJ; Kobayashi T; Obama T; Tsuji T; Elliott KJ; Hashimoto T; Rizzo V; Eguchi S
Clin Sci (Lond); 2014 Jun; 126(11):785-94. PubMed ID: 24329494
[TBL] [Abstract][Full Text] [Related]
11. ERK1/2 mediate wounding- and G-protein-coupled receptor ligands-induced EGFR activation via regulating ADAM17 and HB-EGF shedding.
Yin J; Yu FS
Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):132-9. PubMed ID: 18658095
[TBL] [Abstract][Full Text] [Related]
12. Ectodomain shedding of pro-TGF-alpha is required for COX-2 induction and cell survival in renal medullary cells exposed to osmotic stress.
Küper C; Bartels H; Fraek ML; Beck FX; Neuhofer W
Am J Physiol Cell Physiol; 2007 Dec; 293(6):C1971-82. PubMed ID: 17942633
[TBL] [Abstract][Full Text] [Related]
13. Helicobacter pylori-induced gastric mucosal TGF-α ectodomain shedding and EGFR transactivation involves Rac1/p38 MAPK-dependent TACE activation.
Slomiany BL; Slomiany A
Inflammopharmacology; 2016 Feb; 24(1):23-31. PubMed ID: 26658844
[TBL] [Abstract][Full Text] [Related]
14. A Lactobacillus rhamnosus GG-derived soluble protein, p40, stimulates ligand release from intestinal epithelial cells to transactivate epidermal growth factor receptor.
Yan F; Liu L; Dempsey PJ; Tsai YH; Raines EW; Wilson CL; Cao H; Cao Z; Liu L; Polk DB
J Biol Chem; 2013 Oct; 288(42):30742-30751. PubMed ID: 24043629
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor-alpha converting enzyme (TACE) regulates epidermal growth factor receptor ligand availability.
Sunnarborg SW; Hinkle CL; Stevenson M; Russell WE; Raska CS; Peschon JJ; Castner BJ; Gerhart MJ; Paxton RJ; Black RA; Lee DC
J Biol Chem; 2002 Apr; 277(15):12838-45. PubMed ID: 11823465
[TBL] [Abstract][Full Text] [Related]
16. Migration of growth factor-stimulated epithelial and endothelial cells depends on EGFR transactivation by ADAM17.
Maretzky T; Evers A; Zhou W; Swendeman SL; Wong PM; Rafii S; Reiss K; Blobel CP
Nat Commun; 2011; 2():229. PubMed ID: 21407195
[TBL] [Abstract][Full Text] [Related]
17. P2Y2 nucleotide receptors mediate metalloprotease-dependent phosphorylation of epidermal growth factor receptor and ErbB3 in human salivary gland cells.
Ratchford AM; Baker OJ; Camden JM; Rikka S; Petris MJ; Seye CI; Erb L; Weisman GA
J Biol Chem; 2010 Mar; 285(10):7545-55. PubMed ID: 20064929
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoids induce cancer cell proliferation via tumor necrosis factor alpha-converting enzyme (TACE/ADAM17)-mediated transactivation of the epidermal growth factor receptor.
Hart S; Fischer OM; Ullrich A
Cancer Res; 2004 Mar; 64(6):1943-50. PubMed ID: 15026328
[TBL] [Abstract][Full Text] [Related]
19. Direct activation of TACE-mediated ectodomain shedding by p38 MAP kinase regulates EGF receptor-dependent cell proliferation.
Xu P; Derynck R
Mol Cell; 2010 Feb; 37(4):551-66. PubMed ID: 20188673
[TBL] [Abstract][Full Text] [Related]
20. TACE/ADAM-17: a component of the epidermal growth factor receptor axis and a promising therapeutic target in colorectal cancer.
Merchant NB; Voskresensky I; Rogers CM; Lafleur B; Dempsey PJ; Graves-Deal R; Revetta F; Foutch AC; Rothenberg ML; Washington MK; Coffey RJ
Clin Cancer Res; 2008 Feb; 14(4):1182-91. PubMed ID: 18281553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
